212 related articles for article (PubMed ID: 37967443)
21. Considerations for the use of proton-pump inhibitors in older adults.
Desilets AR; Asal NJ; Dunican KC
Consult Pharm; 2012 Feb; 27(2):114-20. PubMed ID: 22330952
[TBL] [Abstract][Full Text] [Related]
22. SAFETY OF LONG-TERM PROTON PUMP INHIBITORS: FACTS AND MYTHS.
Chinzon D; Domingues G; Tosetto N; Perrotti M
Arq Gastroenterol; 2022; 59(2):219-225. PubMed ID: 35830032
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of Prescribing Appropriateness and Initiatives to Improve Prescribing of Proton Pump Inhibitors at Vancouver General Hospital.
Wan A; Halpape K; Talkhi SC; Dixon C; Dossa H; Tabamo J; Roberts M; Dahri K
Can J Hosp Pharm; 2018; 71(5):308-315. PubMed ID: 30401997
[TBL] [Abstract][Full Text] [Related]
24. Common gastrointestinal symptoms: risks of long-term proton pump inhibitor therapy.
Fashner J; Gitu AC
FP Essent; 2013 Oct; 413():29-39. PubMed ID: 24124705
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of proton pump inhibitors induced risk of community-acquired pneumonia.
Nguyen PA; Islam M; Galvin CJ; Chang CC; An SY; Yang HC; Huang CW; Li YJ; Iqbal U
Int J Qual Health Care; 2020 Jun; 32(5):292-299. PubMed ID: 32436582
[TBL] [Abstract][Full Text] [Related]
26. The Effects of Proton Pump Inhibitors in Acid Hypersecretion-Induced Vitamin B12 Deficiency: A Systematic Review (2022).
Swarnakari KM; Bai M; Manoharan MP; Raja R; Jamil A; Csendes D; Gutlapalli SD; Prakash K; Desai DM; Desai A; Khan S
Cureus; 2022 Nov; 14(11):e31672. PubMed ID: 36545170
[TBL] [Abstract][Full Text] [Related]
27. Perils and pitfalls of long-term effects of proton pump inhibitors.
Wilhelm SM; Rjater RG; Kale-Pradhan PB
Expert Rev Clin Pharmacol; 2013 Jul; 6(4):443-51. PubMed ID: 23927671
[TBL] [Abstract][Full Text] [Related]
28. Proton Pump Inhibitor use in Hospitalized Patients: Is Overutilization Becoming a Problem?
Durand C; Willett KC; Desilets AR
Clin Med Insights Gastroenterol; 2012; 5():65-76. PubMed ID: 24833936
[TBL] [Abstract][Full Text] [Related]
29. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
[TBL] [Abstract][Full Text] [Related]
30. Review of Proton Pump Inhibitor Overuse in the US Veteran Population.
Metaxas ES; Bain KT
J Pharm Technol; 2015 Aug; 31(4):167-176. PubMed ID: 34860933
[No Abstract] [Full Text] [Related]
31. [What is the REAL long-term risk of proton pump inhibitors?].
Ribiere S; Guillaumot MA; Barré A; Abou Ali E; Barret M; Chaussade S; Coriat R
Presse Med; 2019 May; 48(5):503-510. PubMed ID: 30926204
[TBL] [Abstract][Full Text] [Related]
32. Association of Vitamin B12 deficiency with long-term PPIs use: A cohort study.
Mumtaz H; Ghafoor B; Saghir H; Tariq M; Dahar K; Ali SH; Waheed ST; Syed AA
Ann Med Surg (Lond); 2022 Oct; 82():104762. PubMed ID: 36268318
[TBL] [Abstract][Full Text] [Related]
33. Proton pump inhibitors for functional dyspepsia.
Pinto-Sanchez MI; Yuan Y; Hassan A; Bercik P; Moayyedi P
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011194. PubMed ID: 29161458
[TBL] [Abstract][Full Text] [Related]
34. Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors.
Maideen NMP
Chonnam Med J; 2023 May; 59(2):115-127. PubMed ID: 37303818
[TBL] [Abstract][Full Text] [Related]
35. Proton pump inhibitor use: systematic review of global trends and practices.
Shanika LGT; Reynolds A; Pattison S; Braund R
Eur J Clin Pharmacol; 2023 Sep; 79(9):1159-1172. PubMed ID: 37420019
[TBL] [Abstract][Full Text] [Related]
36. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review.
Targownik LE; Fisher DA; Saini SD
Gastroenterology; 2022 Apr; 162(4):1334-1342. PubMed ID: 35183361
[TBL] [Abstract][Full Text] [Related]
37. Adverse Effects of Proton Pump Inhibitors on Platelet Count: A Case Report and Review of the Literature.
Mukherjee S; Jana T; Pan JJ
Case Rep Gastrointest Med; 2018; 2018():4294805. PubMed ID: 29854491
[TBL] [Abstract][Full Text] [Related]
38. Quantifying Candidacy for Deprescribing of Proton Pump Inhibitors among Long-Term Care Residents.
Doell A; Walus A; To J; Bell A
Can J Hosp Pharm; 2018; 71(5):302-307. PubMed ID: 30401996
[TBL] [Abstract][Full Text] [Related]
39. Administration of proton pump inhibitors in critically ill medical patients is associated with increased risk of developing Clostridium difficile-associated diarrhea.
Buendgens L; Bruensing J; Matthes M; Dückers H; Luedde T; Trautwein C; Tacke F; Koch A
J Crit Care; 2014 Aug; 29(4):696.e11-5. PubMed ID: 24674763
[TBL] [Abstract][Full Text] [Related]
40. [Adverse effects of proton pump inhibitors: should we worry about long-term exposure?].
Roulet L; Vernaz N; Giostra E; Gasche Y; Desmeules J
Rev Med Interne; 2012 Aug; 33(8):439-45. PubMed ID: 22284952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
